BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Thursday reported a loss of $10.6 million in its first quarter. On a per-share basis, the Bay ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

LONDON (Reuters) -Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously iterating that low ...

Two biotech stocks make perfect candidates for this sort of strategy right now. One has declined over the past four years, while the other just slipped in recent weeks. Each represents a bargain ...

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

Several hundred job cuts will affect Bay Area workers in the tech, biotech, energy and school sectors, according to official state filings. Bay Area bounces back with job gains, with warnings ...

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Biotech stocks lagged the broader market ...

In this article, we will look at the 10 Best Low-Priced Biotech Stocks to Buy Now. Is Now the Time to Buy Biotech Stocks? On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on ...

If he could control these microscopic snips, UC Berkeley historian Sally Smith Hughes writes in her book, Genentech: The Beginnings of Biotech, he could manipulate “the stuff of life.” Within six ...